References
- Rider C. C., Tayler C. B. Enolase isoenzymes in rat tissues. Electrophoretic, chromatographic and kinetic properties. Biochem. Biophys. Acta. 1974; 365: 285–300
- Schmechel D., Marangos P. J., Brightman M. Neuron-specific enolase is a molecular marker for peripheral and central neuroendocrine cells. Nature 1978; 276: 834–6
- Facer P., Polak J. M., Marangos P. J., Pearse A. G. E. Immunocytochemical location of neurone specific enolase (NSE) in the gastrointestinal tract. Proc. Roy. Microscop. Soc. 1980; 15: 113–4
- Grimelius L., Wilander E. Silver stains in the study of endocrine cells of the gut and pancreas. Invest. Cell. Pathol. 1980; 3: 3–12
- Tapia F. J., Polak J. M., Barbosa A. J. A., Bloom S. R., Marangos P. J., Dermody C. Neuron-specific enolase is produced by neuroendocrine tumours. Lancet 1981; i: 808–11
- Ariyoshi Y., Kato K., Ishiguro Y., Ota K., Sato T., Suchi T. Evaluation of serum neuron-specific enolase as a tumor marker for carcinoma of the lung. GANN 1983; 74: 219–25
- Bergh J., Esscher T., Steinholtz L., Nilsson K., Pahlman S. Immunocytochemical demonstration of neuron-specific enolase (NSE) in human lung cancers. Am. J. Clin. Pathol. 1985; 84: 1–7
- Cooper E. H., Pritchard J., Bailey C. C., Ninane J. Serum neuron-specific enolase in children's cancer. Br. J. Cancer 1987; 56: 65–67
- Yamaguchi K., Seiki M., Yoshida M., Nishimura H., Kawano F., Takatsuki K. The detection of human T-cell leukemia virus provirus DNA and its application for classification and diagnosis of T-cell malignancy. Blood 1984; 63: 1235–40
- Kawano F., Yamaguchi K., Nishimura H., Tsuda H., Takatsuki K. Variations in the clinical courses of adult T-cell leukemia. Cancer 1985; 55: 851–6
- Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposals for the classification of the acute leukemias. Br. J. Haematol. 1976; 33: 451–8
- Asou N., Matsuoka M., Hattori T., Kawano I. F., Maeda S., Shimada K., Takatsuki K. T-cell gene rearrangements in hematologic neoplasms. Blood 1987; 67: 968–70
- Osame M., Usuku K., Izumo S., Ijichi N., Amitani H., Igata A., Matsumoto M., Tara M. HTLV-I associated myelopathy, A new clinical entity. Lancet 1986; i: 1631–2
- Kimura S., Hayano T., Kato K. Properties and application to immunoassay of monoclonal antibodies to neuron-specific enolase. Biochimica et Biophysica Acta. 1984; 799: 252–9
- Greene W. C., Leonard W. J., Depper J. M., Nelson D. L., Waldmann T. A. The human interleukin-2 receptor: Normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses. Ann. Int. Med. 1986; 105: 560–72
- Yasuda N., Lai P., Ip S. H., Kung P. C., Hinuma Y., Matsuoka M., Hattori T., Takatsuki K., Purtilo D. T. Soluble interleukin-2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease. Blood 1988; 71: 1021–26
- Yamaguchi K., Nishimura Y., Kiyokawa T., Takatsuki K. Elevated serum levels of soluble interleukin-2 receptors in HTLV-I associated myelopathy (HAM). J. Lab. Clin. Med. 1989; 114: 407–410
- Gessain A., Barim F., Vernant G. C., Gout O., Maurs L., Calender A., De The G. Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis. Lancet 1985; ii: 407–10
- Nadler L. M., Korsmeyer S. J., Anderson K. C., Boyd A. W., Slaughenhoupt B., Park E., Jensen J., Coral F., Mayer R. J., Sallan S. E., Ritz J., Schlossman S. F. B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation. J. Clin. Invest. 1984; 74: 332–40